Literature DB >> 3009617

Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.

N R Ferreri, W C Howland, H L Spiegelberg.   

Abstract

Purified human peripheral blood monocytes were stimulated with aggregated human myeloma proteins of different classes or the calcium ionophore A23187 and the release of leukotrienes C4 and B4 (LTC4, LTB4), and prostaglandin E2 (PGE2) into the supernatant was determined. The ionophore induced release of 10 +/- 5 ng LTC4/10(6) cells and 25 +/- 8 ng LTB4/10(6) cells. Aggregated IgG, IgA, and IgE, but not IgM or monomeric immunoglobulins (Ig), induced release of LTC4 and LTB4 that was approximately 10 to 20% of that induced by ionophore. In addition, IgG, IgA, and IgE, but not IgM, induced release of PGE2 (range 0.015 to 0.22 ng/10(6) cells). Aggregated Ig induced LTC4, LTB4, and PGE2 release in a dose-dependent manner; maximal leukotriene (LT) release was observed by 30 min, in contrast to PG release, which continued to increase up to 2.5 hr. Both ionophore- and Ig-induced LTC4 and LTB4 release were completely inhibited by removal of calcium from the media and by preincubation of cells with nordihydroguaiaretic acid. Indomethacin inhibited Ig-induced PGE2 release by 80%. Phagocytosis of the Ig aggregates was not required for LT or PGE2 release, since release was not inhibited by cytochalasin B. Release of LTC4, LTB4, and PGE2 induced by IgG, IgA, and IgE, but not IgM, correlated with the presence or absence of monocyte Fc receptors (FcR) as determined by rosette assays. The data suggest that IgG, IgA, and IgE immune complexes mostly likely induce monocyte arachidonic acid metabolism via cross-linking of FcR. The ability of monocytes to release eicosanoids in the absence of phagocytosis suggests that interaction of monocytes with immobilized immune complexes, such as those deposited in blood vessel walls or glomerular basement membranes, could initiate metabolism of arachidonic acid by monocytes. Such a mechanism could contribute to inflammatory reactions characterized by mononuclear cell infiltrates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009617

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Receptors for IgA on phagocytic cells.

Authors:  L Shen
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

Review 3.  IgE and immune defense mechanism.

Authors:  J P Dessaint; A Capron
Journal:  Clin Rev Allergy       Date:  1989

4.  The gene for the human IgA Fc receptor maps to 19q13.4.

Authors:  E J Kremer; V Kalatzis; E Baker; D F Callen; G R Sutherland; C R Maliszewski
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 5.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 6.  Fc epsilon receptor II-positive macrophages and platelets: potent effector cells in allergy and defence against helminth parasites.

Authors:  J P Dessaint; A Capron
Journal:  Springer Semin Immunopathol       Date:  1990

Review 7.  Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities.

Authors:  U F Schade; I Burmeister; E Elekes; R Engel; D T Wolter
Journal:  Blut       Date:  1989-12

8.  Activation of human peripheral blood monocytes by lipoproteins.

Authors:  J L Kelley; M M Rozek; C A Suenram; C J Schwartz
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

9.  Immunoregulatory activities of eicosanoids in the rainbow trout (Oncorhynchus mykiss).

Authors:  J Knight; A F Rowley
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

10.  The effect of ranitidine on cellular immunity in patients with multiple myeloma.

Authors:  H J Nielsen; H Nielsen; F Moesgaard; N Tvede; K Klarlund; B Mansa; A Drivsholm
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.